|Bid||0.0600 x 0|
|Ask||0.0650 x 0|
|Day's Range||0.0600 - 0.0650|
|52 Week Range||0.0300 - 0.2100|
|Beta (5Y Monthly)||1.36|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 17, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Halo Collective Inc. ("Halo") (NEO: HALO) (OTCQX: HCANF) (Germany: A9KN), a vertically integrated cannabis company, announced today that it has entered into a strategic partnership and licensing arrangement with Elegance Brands, Inc. ("Elegance"), an innovative global beverage company, to expand its product-offering dispensaries to include THC-infused beverage products (the "Transaction").
Halo Collective Inc. ("Halo" or the "Company") (NEO: HALO) (OTC: HCANF) (Frankfurt: A9KN) is pleased to announce that the common share purchase warrants of the Company (the "Warrants"), issued in connection with the Company's previously announced overnight marketed public offering of units, have been approved for listing on the Neo Exchange Inc. (the "NEO") and are expected to commence trading on or about May 27, 2021 under the symbol HALO.WT.C.
Halo Collective Inc.'s ("Halo" or the "Company") (NEO: HALO) (OTCQX: HCANF) (Germany: A9KN) wholly-owned subsidiary Bophelo Bioscience & Wellness (Pty) Ltd. ("Bophelo") is partnering with OG DNA Genetics Inc. ("DNA Genetics" or "DNA") to grow premium California-style cannabis in Lesotho. Bopehlo operates a 200-hectare cannabis cultivation site near Mafeteng, the first Special Economic Zone ("SEZ") in Lesotho, Africa.1 DNA Genetics is one of the world's leading creators of high-quality cannabis seeds, whose strains consistently contain high cannabinoid and terpene concentrations. Bophelo and DNA entered a seed purchase agreement giving Bophelo exclusive rights to develop new and existing strains of DNA medical cannabis in Lesotho for export worldwide.